Stockreport

Revolution Medicines to Participate in November 2025 Investor Conferences

Revolution Medicines, Inc.  (RVMD) 
PDF REDWOOD CITY, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies [Read more]